Національний консенсус щодо ведення пацієнток із ендометріозом

National consensus on management patients with endometriosis DOI: https://doi.org/10.18370/2309-4117.2015.24.7-12Keywords: consensus, endometriosis, endometrial heterotopia, estrogensAbstract The National consensus on management patients with endometriosis includes the main issues of epidemiology, clinical manifestations, and diagnostics of this disease. The document also contained evidence-based recommendations on treatment tactics of endometriosis (medical and surgical treatment), secondary prevention of endometriosis. References - SOGC Clinical practice guideline: diagnosis and management of endometriosis. JOGC, 2010. - Sinaii, N., et al. “Differences in characteristics among 1.000 women with endometriosis based on extent of disease.” Fertil Steril, 89(3) (2008): 538–545. - Guideline of the European Society of Human Reproduction and Embryology. Management of endometriosis, 2013. - M ol, B.W., Bayram, N., Lijmer, J.G., Wiegerinck, M.A., et al. “The performance of CA -125 measurement in the detection of endometriosis: a meta-analysis.” Fertil Steril, 70(1998): 1101–1108. - C onsensus on current management of endometriosis. Hum Reprod, 28(6) (2013): 1552–1568. - M ueck, A.O. “Dienogest: an oral progestogen for the treatment of endometriosis.” Expert Review of Obstetrics & Gynecology, 1 (Vol. 6) (2011): 5–15. - Köhler, G., Faustmann, T.A., Gerlinger, C., Seitz, C., Mueck, A.O. “A dose-ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis.” Int J Gynecol Obstet, 108(2010): 21–25. - Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., Seitz, C. “Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.” Hum Reprod, 25(2010): 633–634. - Harada, T., Momoeda, M., Taketani, Y., Aso, T., et al. “Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial.” Fertil Steril, 91(3) (2009): 675–681. - C osson, M., Querleu, D., Donnez, J., Madelenat, P., et al. “Dienogest is as effective astriptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.” Fertil Steril, 77(2002): 684–692. - Schindler, A.E. “Dienogest in long-term treatment of endometriosis.” Int J Womens Health, 3(2011): 175–184. - Schlaff, W.D., Carson, S.A., Luciano, A., Ross, D., Bergqvist, A. “Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.” Fertil Steril, 85(2006): 314–325. - C rosignani, P.G., Luciano, A., Ray, A., Bergqvist, A. “Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.” Hum Reprod, 21(2006): 248–256. - P etta, C.A., Ferriani, R.A., Abrao, M.S., Hassan, D., et al. “Randomized clinical trial of a levonorgestrel -releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.” Hum Reprod, 20(2005): 1993. - Vercellini, P., Aimi, G., Panazza, S., et al. “A levonorgestrel – releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.” Fertil Steril, 72(1999): 505–508. - Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., Raffaelli, R. “Use of a levonorgestrel -releasing intrauterine device in the treatment of rectovaginal endometriosis.” Fertil Steril, 75(2001): 485–488. - W ong, C., et al. “Oral contraceptive pill as treatment for primary dysmenorrhoea.” Cochrane Database Syst Rev (2009). - Yap, C. “Pre and post operative medical therapy for endometriosis surgery.” Cochrane Database Syst Rev, 3(2004): CD003678. Downloads Published How to Cite Issue Section License Copyright (c) 2015 В. М. Запорожан, Т. Ф. Татарчук, В. В. Камінський This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.